The effects of three nonoxynol-9 preparations on vaginal flora and epithelium

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 426-437

  Watts, D Heather ^a,d   Rabe, Lorna ^b   Krohn, Marijane A ^b   Aura, Jan ^a   Hillier, Sharon L ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Dept of Obstet Gynaecol and R ^*  (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANTAGE 24; HYDROGEN PEROXIDE; NONOXINOL 9; UNCLASSIFIED DRUG;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; COLPOSCOPY; CONTRACEPTION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GARDNERELLA VAGINALIS; HUMAN; HUMAN EXPERIMENT; LACTOBACILLUS; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; NORMAL HUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; UREAPLASMA UREALYTICUM; VAGINA EPITHELIUM; VAGINA FLORA;

ADULT; BACTERIA; COLPOSCOPY; ENTEROCOCCUS; EPITHELIUM; ESCHERICHIA COLI; FEMALE; GARDNERELLA VAGINALIS; GRAM-NEGATIVE ANAEROBIC BACTERIA; HUMANS; LACTOBACILLUS; NONOXYNOL; SPERMATOCIDAL AGENTS; VAGINA;

EID: 0033508965     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314881     Document Type: Article

References (33)

1. 1. Hira SK, Feldblum PJ, Kamanga J, Mukelabai G, Weir SS, Thomas JC. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int J STD AIDS 1997; 8:243-50.
2. 2. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158:518-23.
3. 3. Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339:1371-5.
4. 4. Kreiss J, Ngugi E, Holmes KK, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268:477-82.
5. 5. Zekeng L, Feldblum PJ, Oliver RM, Kaptue L. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 1993; 7: 725-31.
6. 6. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339:504-10.
7. 7. Fihn SD, Latham RH, Roberts P, et al. Association between diaphragm use and urinary tract infection. JAMA 1985; 254:240-5.
8. 8. Percival-Smith R, Bartlett KH, Chow AW. Vaginal colonization of Escherichia coli and its relation to contraceptive methods. Contraception 1983; 27:497-504.
9. 9. Fihn SD, Boyko EJ, Normand EH, et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol 1996; 144:512-20.
10. 10. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standard method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
11. 11. Baron EJ, Sting CA, McTeague M, Vaisanen MC, Feingold SM. Survival of anaerobes in original specimens transported by overnight mail services. Clin Infect Dis 1995; 20(Suppl 2):S174-7.
12. 12. Martius J, Krohn MA, Hillier SL, et al. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988; 71:89-95.
13. 13. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-5.
14. 2-producing Lactobacillus, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993; 16(Suppl 4):S273-81.
15. 15. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256: 1899-903.
16. 16. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989; 27:251-6.
17. 17. Fisher LD, Van Belle G. Biostatistics: a methodology for the health sciences. New York: Wiley and Sons, 1993.
18. 18. Siegel S. Non-parametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956.
19. 19. Klebanoff SJ. Effects of the spermicidal agent nonoxynol-9 on vaginal microbial flora. J Infect Dis 1992; 165:19-25.
20. 20. Hooton TM, Fennell CL, Clark AM, et al. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelia cells. J Infect Dis 1991; 164:1216-9.
21. 21. McGroarty JA, Tomeczek L, Pond DG, Reid G, Bruce AW. Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9. J Infect Dis 1992; 165:1142-4.
22. 22. Richardson BA, Martin HL Jr, Stevens CE, et al. Use of nonoxynol-9 and changes in vaginal lactobacilli. J Infect Dis 1998; 178:441-5.
23. 23. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-63.
24. 24. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosis associated microorganisms in endometritis. Am J Obstet Gynecol 1996; 175:435-41.
25. 25. Larsson PG, Platz-Christensen JJ, Thejls H, Forsum U, Pahlson C. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am J Obstet Gynecol 1992; 166:100-3.
26. 26. Watts DH, Krohn MA, Hillier SL. Eschenbach DA. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol 1990; 75:52-8.
27. 27. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990; 163:1016-21.
28. 28. Taha TE, Hoover DR, Dallabetta A, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998; 12:1699-706.
29. 29: Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 1990; 163:510-4.
30. 30. Foxman B, Frerichs RR. Epidemiology of urinary tract infection. I. Diaphragm use and sexual intercourse. Am J Public Health 1985; 75:1308-13.
31. 31. Hooton TM, Hillier S, Johnson C, et al. Escherichia coli bacteriuria and contraceptive method. JAMA 1991; 265:64-9.
32. 32. Rosenstein IJ, Stafford MK, Kitchen VS, Ward H, Weber JN, Taylor-Robinson D. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J Infect Dis 1998; 177:1386-90.
33. 33. Martin HL, Stevens CE, Richardson BA, et al. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. Sex Transm Dis 1997; 24:279-83.